Gemcitabine remains a mainstay in cancer treatment, but scientists are exploring how it can work alongside cutting-edge therapies. While some drug combinations have failed to improve outcomes, other ...

Cancer cocktails pairing Moderna’s mRNA-4359 with Merck’s Keytruda and Marengo’s invikafusp alfa with Gilead Sciences’ ...

In this segment on advanced renal cell carcinoma, Dr. Wulff explores how the potential incorporation of belzutifan-based ...

FDA accepts Zanidatamab combo sBLA for HER2+ gastroesophageal cancer, showing improved outcomes in HERIZON-GEA-01 trial with ...

Priority Review and Real-Time Oncology Review aim to accelerate regulatory assessment of zanidatamab-based first-line ...

OpenAI says it has already put GPT-5.5’s coding skills to use internally. The LLM helped optimize the software that manages ...

In Little Alchemy and Little Alchemy 2, the machine is a major milestone that represents technology, automation, and human innovation. Creating a machine unlocks advanced combinations involving tools, ...

In Little Alchemy and Little Alchemy 2, the Sun is a powerful and essential element that represents energy, light, and the center of planetary systems. Creating the sun unlocks advanced combinations ...

Neeraj Agarwal and Tanya Dorff discuss the expanding role of PARP inhibitors in prostate cancer treatment. Both clinicians emphasize conducting next-generation sequencing testing earlier in metastatic ...

Three-color combinations have also been around since the beginning, and only received lore-friendly naming conventions for the five Allied-color combinations with Shards of Alara (2008), and the five ...

New immunotherapy drug combinations are significantly extending survival for patients with advanced kidney cancer, one of the fastest-growing cancers in the United States, according to oncologists and ...